1. Repositório Institucional da Universidade Federal de Sergipe - RI/UFS
  2. PRODUÇÃO CIENTÍFICA
  3. DME - Departamento de Medicina
  4. DME - Artigos de periódicos
Use este identificador para citar ou linkar para este item: https://ri.ufs.br/jspui/handle/riufs/25186
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorChien, Hsin Fen-
dc.contributor.authorRosso, Ana Lucia Zuma de-
dc.contributor.authorSantos, André Sobierajski dos-
dc.contributor.authorRieder, Carlos Roberto de Mello-
dc.contributor.authorMaia, Debora Palma-
dc.contributor.authorSilva, Delson José da-
dc.contributor.authorAndrade, Marcio da Cunha-
dc.contributor.authorColetta, Marcus Vinicius Della-
dc.contributor.authorCosta, Maria do Desterro Leiros da-
dc.contributor.authorAllam, Nasser-
dc.contributor.authorPrado, Roberto César Pereira do-
dc.contributor.authorBorges, Vanderci-
dc.contributor.authorTumas, Vitor-
dc.contributor.authorHorta, Wagner de Goes-
dc.date.accessioned2026-07-06T19:07:32Z-
dc.date.available2026-07-06T19:07:32Z-
dc.date.issued2016-
dc.identifier.citationCHIEN, H. F. et al. Brief considerations on the dispensation profile of the botulinum toxin type A by the Brazilian Unified Health System for treatment of dystonias: Datasus data. eNeurologicalSci, Amsterdam, v. 5, p. 11–14, 2016. Disponível em: https://www.sciencedirect.com/science/article/pii/S2405650216300260?ref=pdf_download&fr=RR-2&rr=a02f0646f8c9d4ad. Acesso em: 28 maio 2026.pt_BR
dc.identifier.issn2405-6502-
dc.identifier.urihttps://ri.ufs.br/jspui/handle/riufs/25186-
dc.languageengpt_BR
dc.publisherElsevier BVpt_BR
dc.relation.ispartofeNeurologicalScipt_BR
dc.subjectBotulinum toxineng
dc.subjectDystoniaeng
dc.subjectFacial spasmeng
dc.subjectBlepharospasmeng
dc.titleBrief considerations on the dispensation profile of the botulinum toxin type A by the Brazilian Unified Health System for treatment of dystonias: Datasus datapt_BR
dc.typeArtigopt_BR
dc.identifier.licenseCreative Commons Atribuição 4.0 Internacional (CC BY 4.0)pt_BR
dc.description.resumoBotulinum toxin injections are the most effective approach for the treatment of focal dystonia. Despite growing demand and clinical indications over the years, there are few reports or publications of its use and benefit to patients seen at the Sistema Único de Saúde - SUS (Unified Health System). Analyzing the Datasus data (Unified Health System Information Department of Brazilian Ministry of Health), it was noticed that in Brazil the percentage of dystonic patient benefited from this procedure is still low.We therefore suggest some strategies to increase the dispensation of the toxin by the Brazilian Unified Health system for the dystonic patients.pt_BR
dc.description.localAmsterdampt_BR
dc.identifier.doihttp://dx.doi.org/10.1016/j.ensci.2016.07.001-
Aparece nas coleções:DME - Artigos de periódicos

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
BriefConsiderationDispensationProfileBotulinumToxin.pdf660,56 kBAdobe PDFThumbnail
Visualizar/Abrir
Mostrar registro simples do item Visualizar estatísticas


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.